The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-chloro-4-methylphenyl)-2-[4-[(2,4-dioxothiazolidin-5-ylidene)methyl]phenoxy]acetamide ID: ALA4797525
PubChem CID: 49890615
Max Phase: Preclinical
Molecular Formula: C19H15ClN2O4S
Molecular Weight: 402.86
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(NC(=O)COc2ccc(/C=C3\SC(=O)NC3=O)cc2)cc1Cl
Standard InChI: InChI=1S/C19H15ClN2O4S/c1-11-2-5-13(9-15(11)20)21-17(23)10-26-14-6-3-12(4-7-14)8-16-18(24)22-19(25)27-16/h2-9H,10H2,1H3,(H,21,23)(H,22,24,25)/b16-8-
Standard InChI Key: DKMKNOQELNTRJX-PXNMLYILSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
32.8100 -15.3533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8089 -16.1769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5211 -16.5900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2307 -16.1764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2279 -15.3497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5193 -14.9444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9382 -14.9384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6516 -15.3443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7392 -16.1602 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
36.5433 -16.3313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9534 -15.6178 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.4001 -15.0086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8826 -17.0807 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.5665 -14.2044 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.0967 -16.5891 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.3852 -16.1758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6731 -16.5880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9616 -16.1747 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.6724 -17.4093 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.2528 -16.5814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5481 -16.1701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8398 -16.5762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8372 -17.3942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5489 -17.8045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2542 -17.3961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5496 -18.6217 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.1290 -17.8019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 8 1 0
10 13 2 0
12 14 2 0
2 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
24 26 1 0
23 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 402.86Molecular Weight (Monoisotopic): 402.0441AlogP: 3.99#Rotatable Bonds: 5Polar Surface Area: 84.50Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.20CX Basic pKa: ┄CX LogP: 3.72CX LogD: 2.57Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.74Np Likeness Score: -1.97
References 1. Joshi H,Patil V,Tilekar K,Upadhyay N,Gota V,Ramaa CS. (2020) Benzylidene thiazolidinediones: Synthesis, in vitro investigations of antiproliferative mechanisms and in vivo efficacy determination in combination with Imatinib., 30 (23.0): [PMID:32961322 ] [10.1016/j.bmcl.2020.127561 ]